Bayer and Thermo Fisher Will Collaborate on NGS Companion Diagnostic Assays
The collaboration aims to help identify patients who may benefit from precision cancer therapies by offering decentralized genomic testing.
Read MorePosted by Andy Lundin | Mar 20, 2024 | Molecular Diagnostics |
The collaboration aims to help identify patients who may benefit from precision cancer therapies by offering decentralized genomic testing.
Read MorePosted by Chris Wolski | Mar 20, 2024 | Molecular Diagnostics |
Sherlock Bio is making its proprietary AI platform freely available to anyone interested in developing diagnostics assays.
Read MorePosted by Chris Wolski | Mar 15, 2024 | Miscellaneous |
Data shows how computational indexing combined with a systematic literature review can be used to characterize gene-disease relationships.
Read MorePosted by Andy Lundin | Mar 15, 2024 | Hematology Instrumentation, Lab Automation |
The hematology automation system aims to transform the capabilities of the hospital and facilitate the measurement of complete blood counts.
Read MorePosted by Andy Lundin | Mar 14, 2024 | Breast |
The AidaBreast novel biosignature also predicts radiation therapy benefit for early-stage invasive breast cancer patients.
Read More